Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 1
2012 2
2013 3
2014 1
2015 1
2016 4
2017 5
2018 6
2019 6
2020 9
2021 12
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

46 results
Results by year
Filters applied: . Clear all
Page 1
Role of the Scavenger Receptor CD36 in Accelerated Diabetic Atherosclerosis.
Navas-Madroñal M, Castelblanco E, Camacho M, Consegal M, Ramirez-Morros A, Sarrias MR, Perez P, Alonso N, Galán M, Mauricio D. Navas-Madroñal M, et al. Among authors: castelblanco e. Int J Mol Sci. 2020 Oct 5;21(19):7360. doi: 10.3390/ijms21197360. Int J Mol Sci. 2020. PMID: 33028031 Free PMC article.
1H-magnetic resonance spectroscopy lipoprotein profile in patients with chronic heart failure versus matched controls.
Teis A, Castelblanco E, Cediel G, Amigó N, Julve J, Ribalta J, Guardiola M, Franch J, Bermúdez-López M, Codina P, Lupón J, Mauricio D, Alonso N, Bayés-Genís A. Teis A, et al. Among authors: castelblanco e. Rev Esp Cardiol (Engl Ed). 2021 Oct 26:S1885-5857(21)00285-1. doi: 10.1016/j.rec.2021.09.008. Online ahead of print. Rev Esp Cardiol (Engl Ed). 2021. PMID: 34716123 English, Spanish.
Circulating CD5L is associated with cardiovascular events and all-cause mortality in individuals with chronic kidney disease.
Castelblanco E, Sarrias MR, Betriu À, Soldevila B, Barranco-Altirriba M, Franch-Nadal J, Valdivielso JM, Bermudez-Lopez M, Groop PH, Fernández E, Alonso N, Mauricio D. Castelblanco E, et al. Aging (Albany NY). 2021 Oct 10;13(19):22690-22709. doi: 10.18632/aging.203615. Epub 2021 Oct 10. Aging (Albany NY). 2021. PMID: 34629330 Free PMC article.
Cardiovascular and mortality benefits of sodium-glucose co-transporter-2 inhibitors in patients with type 2 diabetes mellitus: CVD-Real Catalonia.
Real J, Vlacho B, Ortega E, Vallés JA, Mata-Cases M, Castelblanco E, Wittbrodt ET, Fenici P, Kosiborod M, Mauricio D, Franch-Nadal J. Real J, et al. Among authors: castelblanco e. Cardiovasc Diabetol. 2021 Jul 9;20(1):139. doi: 10.1186/s12933-021-01323-5. Cardiovasc Diabetol. 2021. PMID: 34243779 Free PMC article.
Atherogenic dyslipidemia, but not hyperglycemia, is an independent factor associated with liver fibrosis in subjects with type 2 diabetes and NAFLD: a population-based study.
Julián MT, Pera G, Soldevila B, Caballería L, Julve J, Puig-Jové C, Morillas R, Torán P, Expósito C, Puig-Domingo M, Castelblanco E, Franch-Nadal J, Cusi K, Mauricio D, Alonso N. Julián MT, et al. Among authors: castelblanco e. Eur J Endocrinol. 2021 Apr;184(4):587-596. doi: 10.1530/EJE-20-1240. Eur J Endocrinol. 2021. PMID: 33606661
46 results